Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer

Overview of attention for article published in Molecular Cancer, February 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

So far, Altmetric has seen 2 news stories from 2 outlets.

Share on PinterestResearchers are studying the effectiveness of osimertinib in treating some types of lung cancer.

Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1 November 3, 2020 Source:drugdu…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.